Edge AI Tech Challenge

IMpatient Innovation awards 2025

On the opening night of SNX 2025, the Impatient Innovation Awards will honor the Israeli mindset of doing first, adapting fast, and finding opportunity in constraint. This is your chance to shine the spotlight on an innovator who moves with purpose and turns challenges into action.

About the Challange

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in 

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Asif Meetup

What You Have A Chance To Win?

On-Stage Spotlight

During SNX 2025 opening ceremony and awards
(November 3, 2025)

Media Exposure

Through SNX 2025 conference and
Startup Nation Central channels

Access Network

Global partners, investors, and
business leaders attending SNX 2025

Who Is This Challenge For?

This challenge is intentionally sector-agnostic. You do not need to be an “AI infrastructure company” or a semiconductor startup to apply. If your solution benefits from fast, local intelligence, edge AI is already relevant. Individuals and teams can apply, even if they are not registered companies. But all applicants must submit at least a mockup or proof of concept, and participants must be based in Israel.

We encourage applications from the following sectors: 

  • Health, medical devices, and digital health 
  • Mobility, robotics, drones, and autonomy 
  • Industrial tech, manufacturing, and IoT 
  • Climate, energy, agriculture, and water 
  • Retail, logistics, and smart infrastructure 
  • Consumer devices, wearables, and smart assistants 
  • Security, safety, and situational awareness 
  • Remote monitoring technologies, including solutions for remote blood testing (e.g., chemistry panels) and adverse event tracking.
  • Technologies or services that improve patient experience and accessibility while minimizing daily disruptions.
  • Novel approaches for managing CLL-related fatigue and pain.
  • Digital health tools, wearables, or therapeutics that support symptom relief and overall well-being.
  • Patient-centric innovations that empower individuals to lead active and fulfilling lives

AbbVie Israel welcomes any additional solutions that improve quality of care or quality of life for CLL patients and their caregivers.

TRL 5

Solutions should have a Technology Readiness Level (TRL) of 5 and above.

Focus Area

Preference will be given to solutions addressing the areas of focus.

Multi-Use

Good solutions will address at least one focus area, while great solutions will tackle multiple areas, including technologies.

EMR-Ready

Priority will be given to solutions that integrate with Electronic Medical Records (EMR) based on FHIR.

Nominate an Innovator

Celebrating Bold, Determined Disruptors

Honoring the problem-solvers who move first, act fast, tackle urgent challenges, and deliver lasting impact

Timeline

Febuary 1
Nominations Open
October 15
Nominations Close
October 22
Finalists Announced
November 3
SNX Opening Ceremony
November 4
SNX 2025
Apply Here

Advisory Committee

Yael Gruenbaum

Dr. Yael Gruenbaum-Cohen

Partner

aMoon Fund

dr avi matan

Dr. Avi Matan

General Manager

AbbVie Israel

Tamar Tadmor

Prof. Tamar Tadmor

Clinical Associate Professor Head of Hematology unit Bnai-Zion Medical Center

Giora Sharf

CEO

Flute of Light and CML Patients Organizations

Tamoschus David

Dr. David Tamoschus

Commercial Director, Venclyxto CLL, Oncology, Europe

AbbVie

Yair Hershno

Prof. Yair Herishanu

Hematology Specialist, Director of the CLL Unit and the Hematology Clinic

Ichilov Medical Center

Liat Alon

Liat Alon

CEX Director

AbbVie Israel

Moran Barak 2

Dr. Moran Barak

Medical Director

AbbVie Israel

Iris Adler

Dr. Iris Adler

Head of BD & Global Partnerships

8400 Health Network

Nataly Hason 2

Nataly Hason

Oncology Commercial Director

AbbVie Israel

Startup Nation Central is a free-acting NGO providing global solution seekers frictionless access to Israel’s bold and impatient innovators to help tackle the world’s most pressing challenges.

Looking forward to seeing you at the event